Variant report
Variant | esv3351174 |
---|---|
Chromosome Location | chr17:46713305-46713583 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:13)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:13 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BCL3 | chr17:46713446-46714486 | A549 | lung: | n/a | n/a |
2 | CTCF | chr17:46713525-46714470 | SK-N-SH | brain: | n/a | n/a |
3 | CTCF | chr17:46713320-46713570 | GM12875 | blood: | n/a | n/a |
4 | CTCF | chr17:46713300-46713450 | HRE | kidney: | n/a | n/a |
5 | CTCF | chr17:46712775-46715311 | A549 | lung: | n/a | chr17:46713050-46713059 chr17:46713046-46713059 chr17:46715210-46715223 |
6 | CTCF | chr17:46713540-46713690 | GM12864 | blood: | n/a | n/a |
7 | CTCF | chr17:46713520-46713670 | BE2_C | brain: | n/a | n/a |
8 | CTCF | chr17:46713440-46713590 | SAEC | small airway: | n/a | n/a |
9 | CTCF | chr17:46713440-46713590 | GM12872 | blood: | n/a | n/a |
10 | CTCF | chr17:46713560-46713710 | AG04449 | skin: | n/a | n/a |
11 | CTCF | chr17:46713540-46713690 | NHLF | lung: | n/a | n/a |
12 | NR2F2 | chr17:46713448-46714148 | K562 | blood: | n/a | n/a |
13 | ZNF384 | chr17:46713523-46714203 | K562 | blood: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-HOXB7-1 | chr17:46713285-46714135 | ENSG00000272763.1 |
2 | lnc-HOXB7-1 | chr17:46710876-46714135 | ENSG00000260027.1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
MIR196A1 | TF binding region |
HOXB7 | TF binding region |
ENSG00000272763 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs529137318 | chr17:46713309-46713310 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Genic enhancers Strong transcription | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs117595998 | chr17:46713327-46713328 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Genic enhancers Strong transcription | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs543044674 | chr17:46713340-46713341 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Genic enhancers Strong transcription | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs186994295 | chr17:46713361-46713362 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Genic enhancers Strong transcription | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs149698818 | chr17:46713362-46713363 | Enhancers Bivalent Enhancer Weak transcription Bivalent/Poised TSS Genic enhancers Strong transcription | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs570981976 | chr17:46713403-46713404 | Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' | TF binding regionChromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs534139636 | chr17:46713406-46713407 | Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' | TF binding regionChromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs554301302 | chr17:46713410-46713411 | Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' | TF binding regionChromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs117867814 | chr17:46713419-46713420 | Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' | TF binding regionChromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
10 | rs191465267 | chr17:46713432-46713433 | Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' | TF binding regionChromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs556325405 | chr17:46713461-46713462 | Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' | TF binding regionChromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
12 | rs184649590 | chr17:46713504-46713505 | Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' | TF binding regionChromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
13 | rs539166133 | chr17:46713511-46713512 | Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' | TF binding regionChromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
14 | rs559118309 | chr17:46713531-46713532 | Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' | TF binding regionChromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
15 | rs3744772 | chr17:46713532-46713533 | Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' | TF binding regionChromatin interactive regionlncRNA | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs540428388 | chr17:46713570-46713571 | Bivalent Enhancer Enhancers Weak transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' | TF binding regionChromatin interactive regionlncRNA | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Melanoma | 18172304 | CNVD |
Moyamoya disease | 22323933 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Cancer | 16751803 | CNVD |
Chordoma | 21602918 | CNVD |
Neurofibromatosis | 20686819 | CNVD |
Peripheral nerve sheath tumors | 20686819 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Breast cancer | 21264507 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Gastric cancer | 17167181 | CNVD |
Breast cancer | 19287154 | CNVD |
Leukemia | 20874852 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 17457667 | CNVD |
Breast cancer | 16951389 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 22048815 | CNVD |
Breast cancer | 17603634 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 20953835 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
TAR Syndrome | 17847015 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 19261255 | CNVD |
Lung cancer | 16773561 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Basal-like breast cancer | 18066063 | CNVD |
Breast cancer | 20031965 | CNVD |
Colorectal cancer | 19287155 | CNVD |
Hereditary breast | 19566914 | CNVD |
Ovarian cancer | 19047089 | CNVD |
Ovarian cancer | 19566914 | CNVD |
Triple-negative breast cancer | 18950515 | CNVD |
Breast cancer | 16846527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 16397240 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Prostate cancer | 17217626 | CNVD |
Non-syndromic sensorineural hearing loss | 21084979 | CNVD |
Autism | 22817714 | CNVD |
Breast cancer | 20409316 | CNVD |
Cancer | 17160897 | CNVD |
Frontotemporal lobar degeneration | 19640594 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 21509527 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:46711400-46714000 | Weak transcription | Pancreas | Pancrea |
2 | chr17:46712400-46713400 | Strong transcription | A549 | lung |
3 | chr17:46712400-46713400 | Genic enhancers | K562 | blood |
4 | chr17:46712400-46713600 | Bivalent Enhancer | Colonic Mucosa | Colon |
5 | chr17:46713000-46713400 | Bivalent/Poised TSS | Rectal Mucosa Donor 29 | rectum |
6 | chr17:46713000-46714000 | Genic enhancers | Rectal Mucosa Donor 31 | rectum |
7 | chr17:46713200-46714400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr17:46713400-46713600 | Genic enhancers | A549 | lung |
9 | chr17:46713400-46713800 | Bivalent Enhancer | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
10 | chr17:46713400-46713800 | Bivalent Enhancer | Primary hematopoietic stem cells short term culture | blood |
11 | chr17:46713400-46713800 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
12 | chr17:46713400-46713800 | Flanking Bivalent TSS/Enh | Rectal Mucosa Donor 29 | rectum |
13 | chr17:46713400-46713800 | Bivalent Enhancer | Sigmoid Colon | Sigmoid Colon |
14 | chr17:46713400-46713800 | Bivalent Enhancer | HUVEC | blood vessel |
15 | chr17:46713400-46713800 | Transcr. at gene 5' and 3' | K562 | blood |
16 | chr17:46713400-46714400 | Bivalent Enhancer | Primary T killer memory cells from peripheral blood | blood |